Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bone Biologics (BBLGW) Other Operating Expenses (2017)

Bone Biologics (BBLGW) has disclosed Other Operating Expenses for 2 consecutive years, with -$3.5 million as the latest value for Q2 2017.

  • Quarterly Other Operating Expenses changed N/A to -$3.5 million in Q2 2017 from the year-ago period, while the trailing twelve-month figure was -$2.7 million through Dec 2017, down 56353.09% year-over-year, with the annual reading at -$2.7 million for FY2017, 56353.09% down from the prior year.
  • Other Operating Expenses for Q2 2017 was -$3.5 million at Bone Biologics, down from $784525.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was $784525.0 in Q1 2017, with the low at -$3.5 million in Q2 2017.